Skip to search formSkip to main contentSkip to account menu

TNFRSF10D gene

Known as: TRAIL RECEPTOR WITH A TRUNCATED DEATH DOMAIN, DECOY RECEPTOR 2, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
As ischemic preconditioning (IPC) represents a potential therapy against cerebral ischemia, the purpose of the present study is… 
2019
2019
Large-scale projects, such as The Cancer Genome Atlas (TCGA), Human Epigenome Project (HEP) and Human Epigenome Atlas (HEA… 
2016
Highly Cited
2015
Highly Cited
2015
Gene-specific methylation alterations in breast cancer have been suggested to occur early in tumorigenesis and have the potential… 
2015
2015
Abstract This study investigated expression profiles of tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL… 
2013
2013
BACKGROUND TRAIL is a transmembrane protein that induces apoptosis in various tissues including alveolar bone. Its in vitro… 
2008
2008
BACKGROUND Allelic losses on chromosome 8p are common in prostate carcinoma, but it is not known exactly how they contribute to… 
2008
2008
SummaryThe therapeutic potential of soluble TRAIL (sTRAIL) in hepatocellular carcinoma (HCC) was studied. The expression of TRAIL… 
Review
2005
Review
2005
RNA interference (RNAi) is a complex process that uses small RNAs of 21–23 nucleotides to guide sequence‐specific silencing of…